Baixar PDF

Outros usuários também visualizaram estes artigos

Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis Mohammadali Jafari; Seyed Alireza Dastgheib; Farzad Ferdosian; Hamid Mirjalili; Hossein Aarafi; Mahmood Noorishadkam; Mahta Mazaheri; Hossein Neamatzadeh;
Hematol Transfus Cell Ther. 2022;44:225-34
The course of COVID-19 in patients with hematological malignancies and risk factors affecting mortality: A cross-sectional study Esma Eryilmaz-Eren; Zeynep Ture; Ay¿in Kilinç-Toker; Serdal Korkmaz; ¿lhami Çelik;
Hematol Transfus Cell Ther. 2024;46:3-7
Association between FY*02N.01 and the severity of COVID-19: initial observations Marina C.A.V. Conrado; Marcia R. Dezan; Valéria Brito Oliveira; Karen Chinoca Ziza; Tila Fanciscani; Vanderson Rocha; Alfredo Mendrone-Júnior; Carla Luana Dinardo;
Hematol Transfus Cell Ther. 2022;44:213-7